MTX3
gene geneOn this page
Summary
MTX3 (metaxin 3, HGNC:24812) is a protein-coding gene on chromosome 5q14.1, encoding Metaxin-3 (Q5HYI7). Could function in transport of proteins into the mitochondrion.
Predicted to be involved in mitochondrion organization. Located in mitochondrion. Part of MIB complex and SAM complex.
Source: NCBI Gene 345778 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 54 total
- MANE Select transcript:
NM_001363818
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24812 |
| Approved symbol | MTX3 |
| Name | metaxin 3 |
| Location | 5q14.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000177034 |
| Ensembl biotype | protein_coding |
| OMIM | 619336 |
| Entrez | 345778 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000509852, ENST00000512528, ENST00000512560
RefSeq mRNA: 3 — MANE Select: NM_001363818
NM_001010891, NM_001167741, NM_001363818
CCDS: CCDS47239, CCDS54872, CCDS87308
Canonical transcript exons
ENST00000512528 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001306298 | 79989152 | 79989244 |
| ENSE00001484424 | 79990594 | 79990663 |
| ENSE00001691033 | 79988462 | 79988644 |
| ENSE00001718814 | 79986950 | 79987107 |
| ENSE00001758905 | 79985571 | 79985659 |
| ENSE00001767460 | 79988239 | 79988315 |
| ENSE00002026778 | 79976716 | 79983794 |
| ENSE00003466619 | 79990160 | 79990236 |
| ENSE00003899559 | 79991158 | 79991262 |
Expression profiles
Bgee: expression breadth ubiquitous, 255 present calls, max score 92.05.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 10.1998 / max 146.3959, expressed in 1643 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 62282 | 8.4280 | 1611 |
| 62280 | 1.2526 | 646 |
| 62281 | 0.2778 | 128 |
| 62278 | 0.2414 | 92 |
Top tissues by expression
256 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| oviduct epithelium | UBERON:0004804 | 92.05 | gold quality |
| deltoid | UBERON:0001476 | 91.02 | gold quality |
| tibialis anterior | UBERON:0001385 | 90.93 | gold quality |
| upper arm skin | UBERON:0004263 | 88.81 | gold quality |
| calcaneal tendon | UBERON:0003701 | 87.92 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 87.90 | gold quality |
| pancreatic ductal cell | CL:0002079 | 87.87 | silver quality |
| parotid gland | UBERON:0001831 | 87.65 | gold quality |
| pons | UBERON:0000988 | 87.63 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 86.99 | gold quality |
| ileal mucosa | UBERON:0000331 | 86.92 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 86.79 | gold quality |
| endothelial cell | CL:0000115 | 86.50 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 86.04 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 85.59 | gold quality |
| tendon | UBERON:0000043 | 85.04 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 84.84 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 84.70 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 84.60 | gold quality |
| adrenal tissue | UBERON:0018303 | 84.53 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 84.41 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.01 | gold quality |
| corpus epididymis | UBERON:0004359 | 83.84 | gold quality |
| superficial temporal artery | UBERON:0001614 | 83.82 | gold quality |
| skin of hip | UBERON:0001554 | 83.63 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 83.55 | gold quality |
| caput epididymis | UBERON:0004358 | 83.43 | gold quality |
| medulla oblongata | UBERON:0001896 | 83.20 | gold quality |
| trigeminal ganglion | UBERON:0001675 | 83.17 | gold quality |
| endometrium | UBERON:0001295 | 83.00 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 5.82 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
325 targeting MTX3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-5193 | 100.00 | 67.26 | 1744 |
| HSA-MIR-29A-3P | 100.00 | 73.11 | 1835 |
| HSA-MIR-29B-3P | 100.00 | 73.18 | 1833 |
| HSA-MIR-29C-3P | 100.00 | 73.15 | 1833 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mtx3 | ENSDARG00000090195 |
| mus_musculus | Mtx3 | ENSMUSG00000021704 |
| rattus_norvegicus | Mtx3 | ENSRNOG00000075938 |
| drosophila_melanogaster | CG9393 | FBGN0037710 |
| caenorhabditis_elegans | mtx-1 | WBGENE00009559 |
Paralogs (3): MTX2 (ENSG00000128654), FAXC (ENSG00000146267), MTX1 (ENSG00000173171)
Protein
Protein identifiers
Metaxin-3 — Q5HYI7 (reviewed: Q5HYI7)
All UniProt accessions (1): Q5HYI7
UniProt curated annotations — full annotation on UniProt →
Function. Could function in transport of proteins into the mitochondrion.
Subunit / interactions. Part of a large protein complex spanning both mitochondrial membranes termed the mitochondrial intermembrane space bridging (MIB) complex.
Subcellular location. Mitochondrion. Mitochondrion outer membrane.
Similarity. Belongs to the metaxin family.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5HYI7-1 | 1 | yes |
| Q5HYI7-2 | 2 | |
| Q5HYI7-4 | 3 | |
| Q5HYI7-5 | 4 |
RefSeq proteins (3): NP_001010891, NP_001161213, NP_001350747* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR017410 | Metaxin1/3 | Family |
| IPR019564 | Sam37/metaxin_N | Domain |
| IPR033468 | Metaxin_GST | Domain |
| IPR036282 | Glutathione-S-Trfase_C_sf | Homologous_superfamily |
| IPR040079 | Glutathione_S-Trfase | Family |
| IPR050931 | Mito_Protein_Transport_Metaxin | Family |
Pfam: PF10568, PF17171
UniProt features (12 total): splice variant 5, modified residue 3, chain 1, region of interest 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5HYI7-F1 | 84.60 | 0.65 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (3): 249, 284, 311
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 160 (showing top):
GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE, ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP, GOBP_INNER_MITOCHONDRIAL_MEMBRANE_ORGANIZATION, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE, GOCC_MITOCHONDRIAL_ENVELOPE, GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOBP_MEMBRANE_ORGANIZATION, GOBP_PROTEIN_LOCALIZATION_TO_MITOCHONDRION, GOBP_LOCALIZATION_WITHIN_MEMBRANE, ACEVEDO_LIVER_CANCER_UP, AACTGGA_MIR145, GOBP_PROTEIN_INSERTION_INTO_MEMBRANE, GOCC_OUTER_MITOCHONDRIAL_MEMBRANE_PROTEIN_COMPLEX, AACATTC_MIR4093P, GOCC_ORGANELLE_INNER_MEMBRANE
GO Biological Process (3): mitochondrion organization (GO:0007005), inner mitochondrial membrane organization (GO:0007007), protein transport (GO:0015031)
GO Molecular Function (0):
GO Cellular Component (5): SAM complex (GO:0001401), mitochondrion (GO:0005739), MIB complex (GO:0140275), mitochondrial outer membrane (GO:0005741), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| organelle organization | 1 |
| mitochondrial membrane organization | 1 |
| transport | 1 |
| intracellular protein localization | 1 |
| establishment of protein localization | 1 |
| mitochondrial outer membrane translocase complex | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| inner mitochondrial membrane protein complex | 1 |
| mitochondrial membrane | 1 |
| organelle outer membrane | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
562 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MTX3 | SAMM50 | Q9Y512 | 864 |
| MTX3 | MTX2 | O75431 | 849 |
| MTX3 | TOMM22 | Q9NS69 | 520 |
| MTX3 | DNAJC11 | Q9NVH1 | 519 |
| MTX3 | CHCHD6 | Q9BRQ6 | 513 |
| MTX3 | TOMM7 | Q9P0U1 | 489 |
| MTX3 | AREL1 | O15033 | 472 |
| MTX3 | MTX1 | Q13505 | 464 |
| MTX3 | CHCHD3 | Q9NX63 | 450 |
| MTX3 | OR4N5 | Q8IXE1 | 450 |
| MTX3 | CMYA5 | Q8N3K9 | 431 |
| MTX3 | TIMM21 | Q9BVV7 | 418 |
| MTX3 | TOMM70 | O94826 | 414 |
| MTX3 | TIMM10 | P62072 | 395 |
| MTX3 | TIMM50 | Q3ZCQ8 | 392 |
IntAct
70 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RPS14 | MAGEB2 | psi-mi:“MI:0914”(association) | 0.560 |
| SNRNP27 | UBA6 | psi-mi:“MI:0914”(association) | 0.530 |
| CXCR4 | TMEM120B | psi-mi:“MI:0914”(association) | 0.530 |
| SLC15A1 | METTL15 | psi-mi:“MI:0914”(association) | 0.530 |
| APLNR | METTL15 | psi-mi:“MI:0914”(association) | 0.530 |
| SLC22A9 | GPR89A | psi-mi:“MI:0914”(association) | 0.530 |
| CD68 | TNPO2 | psi-mi:“MI:0914”(association) | 0.530 |
| SLC39A9 | B4GALT5 | psi-mi:“MI:0914”(association) | 0.530 |
| TNF | B4GALT5 | psi-mi:“MI:0914”(association) | 0.530 |
| TMEM171 | THAP12 | psi-mi:“MI:0914”(association) | 0.530 |
| CLEC5A | TSPAN6 | psi-mi:“MI:0914”(association) | 0.530 |
| APOOL | MTX2 | psi-mi:“MI:0914”(association) | 0.530 |
| PTGIR | TMEM63A | psi-mi:“MI:0914”(association) | 0.530 |
| SLC22A16 | APBA3 | psi-mi:“MI:0914”(association) | 0.530 |
| CD244 | MTX2 | psi-mi:“MI:0914”(association) | 0.530 |
| Mtx2 | NRDC | psi-mi:“MI:0914”(association) | 0.350 |
| HSCB | RBP5 | psi-mi:“MI:0914”(association) | 0.350 |
| LRRK2 | psi-mi:“MI:0914”(association) | 0.350 | |
| M | psi-mi:“MI:0914”(association) | 0.350 | |
| BSCL2 | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| SV2A | ILVBL | psi-mi:“MI:0914”(association) | 0.350 |
| MLNR | NBAS | psi-mi:“MI:0914”(association) | 0.350 |
| MAGEA8 | METTL15 | psi-mi:“MI:0914”(association) | 0.350 |
| FAXC | METTL15 | psi-mi:“MI:0914”(association) | 0.350 |
| PTH2R | METTL15 | psi-mi:“MI:0914”(association) | 0.350 |
| CRLF2 | METTL15 | psi-mi:“MI:0914”(association) | 0.350 |
| SPSB4 | CCDC85C | psi-mi:“MI:0914”(association) | 0.350 |
| MGARP | RTL8C | psi-mi:“MI:0914”(association) | 0.350 |
| SLC22A4 | RTL8C | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (115): MTX3 (Affinity Capture-MS), MTX3 (Affinity Capture-MS), MTX3 (Affinity Capture-MS), MTX3 (Affinity Capture-MS), MTX3 (Affinity Capture-MS), MTX3 (Affinity Capture-MS), MTX3 (Affinity Capture-MS), MTX3 (Affinity Capture-MS), MTX3 (Affinity Capture-MS), MTX3 (Affinity Capture-MS), MTX3 (Affinity Capture-MS), MTX3 (Affinity Capture-MS), MTX3 (Affinity Capture-MS), MTX3 (Affinity Capture-MS), MTX3 (Affinity Capture-MS)
ESM2 similar proteins: A0JM23, A4IGD2, A5PKL6, A6NHR9, A6QQZ0, D3ZAT9, F1QWA8, O35099, O88741, O94952, P0CI65, P58005, Q29RL0, Q2TBQ7, Q3U213, Q3UMF9, Q4R6P7, Q4R6Y8, Q5E9N5, Q5F204, Q5HYI7, Q5I0G3, Q5IH14, Q5R5S1, Q5R9R1, Q5RL51, Q5TGI0, Q60649, Q6AZT7, Q6DDI6, Q6DDT5, Q6DEY8, Q6NXY1, Q6YXW6, Q7TNH6, Q7Z494, Q8NBP0, Q8NEC7, Q8TB36, Q94E75
Diamond homologs: A8XWD1, O45503, O75431, P47802, Q13505, Q27HK4, Q2TBS1, Q3KPT9, Q4R3I0, Q4VBW0, Q5HYI7, Q9VHB6, O64471, P34599
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 113 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Mitochondrial protein import | 5 | 10.8× | 9e-03 |
| Mitochondrial biogenesis | 5 | 10.8× | 9e-03 |
| SLC-mediated transmembrane transport | 9 | 6.8× | 1e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
54 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 41 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1051 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 5:79983790:TCCAT:T | acceptor_gain | 1.0000 |
| 5:79983791:CCAT:C | acceptor_gain | 1.0000 |
| 5:79983791:CCATC:C | acceptor_gain | 1.0000 |
| 5:79983792:CAT:C | acceptor_gain | 1.0000 |
| 5:79983792:CATC:C | acceptor_gain | 1.0000 |
| 5:79983793:ATCT:A | acceptor_loss | 1.0000 |
| 5:79983795:C:CC | acceptor_gain | 1.0000 |
| 5:79983795:C:T | acceptor_loss | 1.0000 |
| 5:79983796:T:A | acceptor_loss | 1.0000 |
| 5:79985540:A:C | donor_gain | 1.0000 |
| 5:79985590:T:TA | donor_gain | 1.0000 |
| 5:79985681:C:CT | acceptor_gain | 1.0000 |
| 5:79986944:GCTTA:G | donor_loss | 1.0000 |
| 5:79986945:CTTAC:C | donor_loss | 1.0000 |
| 5:79986946:TTACC:T | donor_loss | 1.0000 |
| 5:79986947:TA:T | donor_loss | 1.0000 |
| 5:79987067:G:C | acceptor_gain | 1.0000 |
| 5:79987067:G:GC | acceptor_gain | 1.0000 |
| 5:79987108:C:CC | acceptor_gain | 1.0000 |
| 5:79988458:ATAC:A | donor_loss | 1.0000 |
| 5:79988459:TA:T | donor_loss | 1.0000 |
| 5:79988460:A:C | donor_loss | 1.0000 |
| 5:79988461:CCTGT:C | donor_loss | 1.0000 |
| 5:79988640:TGAAG:T | acceptor_gain | 1.0000 |
| 5:79988641:GAAG:G | acceptor_gain | 1.0000 |
| 5:79988643:AG:A | acceptor_gain | 1.0000 |
| 5:79988645:C:CC | acceptor_gain | 1.0000 |
| 5:79989144:ACACT:A | donor_loss | 1.0000 |
| 5:79989145:CACTC:C | donor_loss | 1.0000 |
| 5:79989146:ACTCA:A | donor_loss | 1.0000 |
AlphaMissense
2028 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 5:79987078:C:T | G204D | 0.997 |
| 5:79988303:C:G | A173P | 0.996 |
| 5:79989192:G:T | A94D | 0.996 |
| 5:79987090:G:T | A200D | 0.995 |
| 5:79988290:A:G | L177P | 0.995 |
| 5:79989165:A:G | L103P | 0.995 |
| 5:79989180:A:G | L98P | 0.995 |
| 5:79988632:A:G | W112R | 0.993 |
| 5:79988632:A:T | W112R | 0.993 |
| 5:79987079:C:G | G204R | 0.992 |
| 5:79988284:A:G | L179P | 0.992 |
| 5:79988294:A:G | C176R | 0.992 |
| 5:79990663:C:G | A28P | 0.992 |
| 5:79988302:G:T | A173D | 0.991 |
| 5:79989184:C:G | A97P | 0.991 |
| 5:79987021:A:G | L223P | 0.990 |
| 5:79987084:A:T | V202D | 0.990 |
| 5:79988279:A:G | S181P | 0.990 |
| 5:79988281:A:G | L180P | 0.990 |
| 5:79990656:G:T | A30D | 0.990 |
| 5:79989222:A:G | L84P | 0.989 |
| 5:79989232:C:G | D81H | 0.989 |
| 5:79990182:A:T | I69K | 0.989 |
| 5:79987091:C:G | A200P | 0.988 |
| 5:79987094:C:G | D199H | 0.988 |
| 5:79990650:A:G | F32S | 0.988 |
| 5:79990657:C:G | A30P | 0.988 |
| 5:79990662:G:T | A28D | 0.988 |
| 5:79988292:G:C | C176W | 0.987 |
| 5:79989156:G:T | A106E | 0.987 |
dbSNP variants (sampled 300 via entrez): RS1000069361 (5:79986575 G>A), RS1000540580 (5:79979166 A>G), RS1000644949 (5:79979957 G>A), RS1000920327 (5:79991994 C>G,T), RS1001312955 (5:79977931 C>T), RS1001545346 (5:79981038 T>C), RS1001609404 (5:79991513 G>A,C,T), RS1001617410 (5:79981282 A>G), RS1001739225 (5:79985175 G>A,T), RS1001748924 (5:79985040 G>A), RS1001911499 (5:79987640 A>G), RS1001995762 (5:79990028 T>C), RS1002060364 (5:79991213 C>G,T), RS1002082658 (5:79983461 C>A,G,T), RS1002345062 (5:79990298 T>A)
Disease associations
OMIM: gene MIM:619336 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006364_2 | Hepatitis B surface antigen seroclearance in chronic hepatitis B infection | 4.000000e-06 |
| GCST010002_31 | Refractive error | 1.000000e-12 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009345 | Hepatitis B virus surface antigen seropositivity |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
28 total (human), top 28 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression, increases expression | 3 |
| Leflunomide | increases expression | 2 |
| Air Pollutants | decreases expression, increases abundance, increases expression | 2 |
| Cadmium Chloride | decreases expression, increases abundance, increases expression | 2 |
| Particulate Matter | decreases expression, increases abundance, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| FR900359 | increases phosphorylation | 1 |
| alpha phellandrene | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | increases expression | 1 |
| beta-lapachone | increases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| perfluorooctanoic acid | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | decreases expression | 1 |
| jinfukang | decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Folic Acid | decreases expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tunicamycin | increases expression | 1 |
| Thapsigargin | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D9KS | Ubigene HEK293 MTX3 KO | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.